The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115951862 11595186 2 F 201302 20160921 20151006 20160927 EXP CA-ROCHE-1641527 ROCHE 36.13 YR M Y 0.00000 20160927 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115951862 11595186 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW U 103976 375 MG SOLUTION FOR INJECTION QOW
115951862 11595186 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous 375 MG, BIW U 103976 375 MG SOLUTION FOR INJECTION QOW
115951862 11595186 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 103976 SOLUTION FOR INJECTION
115951862 11595186 10 C BRICANYL TERBUTALINE SULFATE 1 Unknown 0
115951862 11595186 11 C ALVESCO CICLESONIDE 1 0
115951862 11595186 12 C VENTOLIN ALBUTEROL SULFATE 1 0
115951862 11595186 13 C NASONEX MOMETASONE FUROATE 1 0
115951862 11595186 14 C CLARITIN LORATADINE 1 0
115951862 11595186 15 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 0
115951862 11595186 16 C NASAL SALINE SODIUM CHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115951862 11595186 1 Asthma
115951862 11595186 10 Product used for unknown indication
115951862 11595186 11 Product used for unknown indication
115951862 11595186 12 Product used for unknown indication
115951862 11595186 13 Product used for unknown indication
115951862 11595186 14 Product used for unknown indication
115951862 11595186 15 Product used for unknown indication
115951862 11595186 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
115951862 11595186 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
115951862 11595186 Body temperature decreased
115951862 11595186 Body temperature increased
115951862 11595186 Cough
115951862 11595186 Headache
115951862 11595186 Lower respiratory tract infection
115951862 11595186 Middle insomnia
115951862 11595186 Nasal congestion
115951862 11595186 Obstructive airways disorder
115951862 11595186 Seasonal allergy
115951862 11595186 Sinusitis
115951862 11595186 Upper-airway cough syndrome
115951862 11595186 Weight increased
115951862 11595186 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115951862 11595186 1 20130123 0
115951862 11595186 2 20130204 0
115951862 11595186 3 20130318 0
115951862 11595186 4 20130905 0
115951862 11595186 5 20131017 0
115951862 11595186 6 20140120 0
115951862 11595186 7 20140303 0
115951862 11595186 8 20140428 0
115951862 11595186 9 20140512 0